SmallCap Sentinel: Courting Colombian
Cannabis
ORLANDO, FL -- January 17,
2019 -- InvestorsHub NewsWire -- The explosion of the
cannabis and hemp market in the United States is no secret to
investors. Stocks related to these industries have been among some
of the most followed in the market as the watershed events of
massive legislative chan ges and an exponentially expanding
consumer market for recreational and medicinal cannabis is
unprecedented. Today's featured company Digipath Inc.
(DIGP) is
well-positioned at the intersection of this opportunity with big
plans to leverage its domestic successes in an enormous new
market.
Many tend to liken the beneficial
legislative changes for marijuana to the End of Prohibition and the
subsequent massive return of alcohol sales. At SmallCap
Sentinel we believe that is a narrow view.
The recently passed Farm Bill
literally liberates the national sale of hemp (and financing for
hemp) and will be absolutely catalytic to the introduction of CBD
in an unlimited amount of products. CBD, the non-psychoactive
element of cannabis found in hemp, is already being mixed into
cosmetics, food, water, creams, and more. So while the removal of
laws that disallowed recreational use can be compared to the End of
Prohibition, the national allowance of hemp production will now be
similar to something like the introduction of plastic in the 1940s
or even grocery refrigeration, a movement that will essentially
change and impact an enormous amount of products. You will begin to
see CBD most everywhere. (Editor's note: try this must read
from Forbeson the Farm Bill and the Future of
Hemp.)
Digipath has staked its claim in
the market as one of the premier cannabis testing laboratories in
the world. In nearly every market where cannabis or hemp is allowed
in any capacity strict laws and quality control are required.
Digipath is an absolute technology leader in creating the highest
standard of testing and accountability, established primarily in
the vast Nevada marijuana and hemp market. Digipath holds the top
levels of testing accreditation and its Chief Science Officer,
Cindy Orser is renowned as an expert in the industry, helping to
create the standards that will allow for research, discovery, and
new products to occur.
What is intriguing about Digipath
is its stated intentions to leverage its pedigree here in the U.S.
and pursue larger and greener pastures in larger international
markets like Colombia in South America. Colombia is believed by
many to soon be one of the top producers of cannabis due to its
favorable climate, environment and strong government
support.
If Digipath can create operational
successes in Colombia and other massive foreign markets- it could
be a game-changer for the established Las Vegas based laboratory.
Certainly, Digipath has the pedigree and proven business model to
pursue these lucrative interests.
About Digipath, Inc. &
Digipath Labs, Inc.
Digipath, Inc. supports the
cannabis industry's best practices for reliable testing, data
acquisition, cannabis education and training, and brings unbiased
cannabis news coverage to the cannabis industry. Digipath Labs
provides pharmaceutical-grade analysis and testing to the cannabis
industry to ensure producers, consumers, and patients know exactly
what is in the cannabis they ingest and to help maximize the
quality of its client's products through analysis, research,
development, and standardization.
About SmallCap
Sentinel:
SmallCap Sentinel is
owned and operated by Emerging Markets Consulting (EMC), a
syndicate of investor relations consultants representing years of
experience. Our network consists of stock brokers, investment
bankers, fund managers, and institutions that actively seek
opportunities in the micro and small-cap equity markets.
For more informative reports such
as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php
Section 17(b) of the Securities Act
of 1933 requires that any person that uses the mails to publish,
give publicity to, or circulate any publication or communication
that describes a security in return for consideration received or
to be received directly or indirectly from an issuer, underwriter,
or dealer, must fully disclose the type of consideration (i.e.
cash, free trading stock, restricted stock, stock options, stock
warrants) and the specific amount of the consideration. In
connection therewith, EMC has received the following compensation
and/or has an agreement to receive in the future certain
compensation, as described below.
We may purchase Securities of the
Profiled Company prior to their securities becoming publicly
traded, which we may later sell publicly before, during or after
our dissemination of the Information, and make profits therefrom.
EMC does not verify or endorse any medical claims for any of its
client companies.
EMC has been paid $10,000 dollars
by Digipath for various marketing services including this report.
EMC does not independently verify any of the content linked-to from
this editorial. A contributor to this report holds 400,000 shares
and receives $3,500 a month for a period of six months for investor
relations services on the behalf of Digipath.
http://emergingmarketsllc.com/disclaimer.php
Emerging Markets Consulting,
LLC
E-mail: jamespainter@emergingmarketsllc.com
Web: www.emergingmarketsllc.com
Digipath (PK) (USOTC:DIGP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Digipath (PK) (USOTC:DIGP)
Historical Stock Chart
From Apr 2023 to Apr 2024